- 301. IFNA2
- [This gene plays a role in signal transduction, the immune response and positive regulation of apoptosis. ( NCI )] (UMLS (NCI) C1334080) IFNA2 Gene;
Interferon, Alpha 2 Gene;
=Gene or Genome | - 351. IL-10C
- [Interleukin-19, encoded by the IL19 gene, is a cytokine that belongs to the IL10 cytokine subfamily. This cytokine is found to be preferentially expressed in monocytes. It can bind the IL20 receptor complex and lead to the activation of the signal transducer and activator of transcription 3 (STAT3). A similar cytokine in mouse is reported to up-regulate the expression of IL6 and TNF-alpha and induce apoptosis, which suggests a role of this cytokine in inflammatory responses. Alternatively spliced transcript variants encoding the distinct isoforms have been described. (From LocusLink) ( NCI )] (UMLS (NCI) C0964553) IL19;
IL-19;
IL19 Protein;
Interleukin 19;
Interleukin 19 Precursor;
Interleukin-19;
Interleukin-19 Precursor;
MDA1;
Melanoma Differentiation Associated Protein-Like Protein;
NG.1;
ZMDA1 =Amino Acid, Peptide, or Protein; Immunologic Factor ;
|
- 302. IFNAR1
- [This gene is involved in tyrosine-kinase signal transduction and receptor mediation. ( NCI )] (UMLS (NCI) C1334081) IFNAR1 Gene;
Interferon (Alpha, Beta and Omega) Receptor 1 Gene;
=Gene or Genome | - 352. IL-12 gene
- [The DNA sequence that encodes the protein cytokine interleukin-12 (IL-12). When introduced as the complementary DNA (cDNA) form into tumor cells by, for example, a genetically engineered adenovirus vector, the transfected IL-12 cDNA expresses IL-12 which activates antitumoral natural killer (NK) cells and CD8+ T-cells and stimulates the secretion of interferon-gamma (IFN-gamma), potentially inhibiting tumor cell metastasis. This gene therapy may also result in IL-12-mediated inhibition of vascular endothelial growth factor (VEGF) and enhancement of matrix metalloproteinases (MMPs). (NCI04) ( NCI )] (UMLS (NCI) C0879338) Interleukin-12 Gene;
pIL-12;
Plasmid DNA Encoding Human Interleukin-12;
Plasmid IL-12;
=Gene or Genome |
- 303. IFNAR2
- [This gene is involved in tyrosine-kinase signal transduction that elicits signaling events in the Jak/Stat and IRS pathways. ( NCI )] (UMLS (NCI) C1334082) IFNAR2 Gene;
Interferon (Alpha, Beta and Omega) Receptor 2 Gene;
=Gene or Genome | - 353. IL-1A/IL-2
- (UMLS (NCI) C0281139) =Therapeutic or Preventive Procedure
|
- 304. IFNG
- [This gene plays a role in signal transduction and immunoregulation. It is also involved in cell communication, migration, growth and proliferation. ( NCI )] (UMLS (NCI) C1334085) IFNG Gene;
Interferon, Gamma Gene;
=Gene or Genome | - 354. IL-1A/indomethacin
- (UMLS (NCI) C0279092) =Therapeutic or Preventive Procedure
|
- 305. IFNGR1
- [This gene is involved in receptor-mediated signal transduction in the interferon gamma signaling pathway. ( NCI )] (UMLS (NCI) C1334083) IFNGR1 Gene;
Interferon Gamma Receptor 1 Gene;
=Gene or Genome | - 355. IL-1A/Indomethacin/VP-16
- (UMLS (NCI) C0281172) =Therapeutic or Preventive Procedure ;
|
- 306. IFNGR2
- [This gene is involved in receptor-mediated signal transduction in the interferon gamma signaling pathway and mediates innate immune responses. ( NCI )] (UMLS (NCI) C1334084) IFNGR2 Gene;
Interferon Gamma Receptor 2 (Interferon Gamma Transducer 1) Gene;
=Gene or Genome | - 356. IL-1A/MTX
- (UMLS (NCI) C0281540) =Therapeutic or Preventive Procedure
|
- 307. IFNW1
- [This gene is involved in signal transduction, cell cycle control and the immune response. ( NCI )] (UMLS (NCI) C1334086) IFNW1 Gene;
Interferon, Omega 1 Gene;
=Gene or Genome | - 357. IL-1B/IL-2
- (UMLS (NCI) C0281166) =Therapeutic or Preventive Procedure ;
|
- 308. Ifosfamide/Paclitaxel/Teniposide
- (UMLS (NCI) C0879442) =Therapeutic or Preventive Procedure ;
| - 358. IL-2/IL-4
- (UMLS (NCI) C0279200) =Therapeutic or Preventive Procedure
|
- 309. Ifoxetine
- (UMLS (NCI) C0123216) =Organic Chemical; Pharmacologic Substance
| - 359. IL-2/IL-4/TIL
- (UMLS (NCI) C0281236) =Therapeutic or Preventive Procedure ;
|
- 310. IFP
- [Encoded by Intermediate Filament Genes, diverse Intermediate Filament Proteins (including keratin filaments, neurofilaments, desmin, and vimentin) form polymeric structural cytoplasmic filaments, intermediate in diameter (8-10 nanometer) between actin microfilaments and microtubules, that comprise part of the cytoskeleton of most eukaryotic cells. (NCI) ( NCI )] (UMLS (NCI) C0021769) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 360. IL-2/IL-6
- (UMLS (NCI) C0281029) =Therapeutic or Preventive Procedure
|
- 311. IgA
- [predominant immunoglobulin in seromucous secretions such as saliva, colostrum, milk, tracheobronchial and genitourinary secretions. ( CSP )] (UMLS (NCI) C0020835) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
=[IM500] IMMUNOGLOBULINS;
| - 361. IL-2/Indomethacin/LAK
- (UMLS (NCI) C0281495) =Therapeutic or Preventive Procedure
|
- 312. IgA Deficient
- (UMLS (HL7) C1548979) =Idea or Concept =Blood Product Processing Requirements;
| - 362. IL-2/LAK/MOAB R24
- (UMLS (NCI) C0280737) =Therapeutic or Preventive Procedure ;
|
- 313. Iganidipine
- (UMLS (NCI) C0666664) =Organic Chemical; Pharmacologic Substance ;
| - 363. IL-2/LEV
- (UMLS (NCI) C0281000) =Therapeutic or Preventive Procedure
|
- 314. IGBP1
- [This gene is involved in multiple signal transduction pathways. ( NCI )] (UMLS (NCI) C1334087) IGBP1 Gene;
Immunoglobulin (CD79A) Binding Protein 1 Gene;
=Gene or Genome | - 364. IL-2/M-CSF
- (UMLS (NCI) C0281350) =Therapeutic or Preventive Procedure
|
- 315. IgD
- [present on the membrane of many circulating B lymphocytes; may play a role in antigen triggered lymphocyte differentiation. ( CSP )] (UMLS (NCI) C0020843) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
=[IM500] IMMUNOGLOBULINS;
| - 365. IL-2/MART-1
- (UMLS (NCI) C0281721) =Therapeutic or Preventive Procedure
|
- 316. IgE
- [found on the surface membrane of basophils and mast cells in all individuals; may play a role in active immunity to helminthic parasites but in developed countries it is more commonly associated with immediate hypersensitivity diseases such as asthma and hay fever. ( CSP )] (UMLS (NCI) C0020846) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
=[IM500] IMMUNOGLOBULINS;
| - 366. IL-2/MLT
- (UMLS (NCI) C0338262) =Therapeutic or Preventive Procedure
|
- 317. IgE immunoassay antibody
- [Immunoassay, IgE Antibody Test ( HL7V3.0 )] (UMLS (HL7) C1553179) =Laboratory Procedure =ObservationMethod;
| - 367. IL-2/MOAB 14G2A
- (UMLS (NCI) C0280841) =Therapeutic or Preventive Procedure
|
- 318. IGF
- [insulin-like polypeptides made by the liver and some fibroblasts and released into the blood when stimulated by somatotropin; they cause sulfate incorporation into collagen, RNA, and DNA synthesis, which are prerequisites to cell division and growth of the organism. ( CSP )] (UMLS (NCI) C0037657) =Amino Acid, Peptide, or Protein; Neuroreactive Substance or Biogenic Amine; Hormone =Growth Agents;
| - 368. IL-2/MOAB 3622W94
- (UMLS (NCI) C0677998) =Therapeutic or Preventive Procedure
|
- 319. IGF binding protein
- [A family of soluble proteins that bind insulin-like growth factors and modulate their biological actions at the cellular level. Serum IGFBP levels have been found to be negatively correlated to the risk of cancer. ( NCI )] (UMLS (CSP) C0074825) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 369. IL-2/MOAB Ch14.18/MOAB R24
- (UMLS (NCI) C0281691) =Therapeutic or Preventive Procedure
|
- 320. IGF Binding Protein 3
- [IGFBP3 belongs to the IGFBP family. IGFBP3 functions as the major carrying protein for IGF1 and IGF2 in the circulation, modulates IGF activity, and inhibits cell growth. IGFBP3 binds IGF-II more than IGF-I. Endothelial IGFBP3 forms a ternary complex with IGF-I or IGF-II and an 85 kD glycoprotein (ALS). IGFBP3 levels increase in the presence of IGF-I, insulin and other growth-stimulating factors such as growth hormone, epidermal growth factor, and phorbol esters. IGFBP3 may control angiogenesis and cell responses in the corpus luteum by autocrine/paracrine mechanisms. IGFBP3 also possesses growth-inhibitory and -potentiating effects that are independent of IGF and are mediated through specific receptors. As a specific IGFBP3-binding protein, transferrin blocks IGFBP3-induced cell proliferation and IGFBP3-induced apoptosis. (from OMIM 146732, SWISS-PROT P17936, and NCI) ( NCI )] (UMLS (NCI) C0123707) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance
| - 370. IL-2/MOAB HuM195
- (UMLS (NCI) C0281728) =Therapeutic or Preventive Procedure
|
- 321. IGF Binding Protein 4
- [IGFBP4 belongs to the IGFBP family. IGFs, IGFRs, and IGFBPs regulate cell proliferation and apoptosis and the primary effect of IGFBPs appears to be modulation of IGF activity and control of IGF-mediated cell growth and metabolism. IGF-I and IGF-II circulate in plasma tightly bound to IGFBPs. Secreted IGFBPs prolong the half-life of IGFs (somatomedins) and either inhibit or stimulate the growth promoting effects of IGFs. They alter the interaction of IGFs with cell surface receptors. IGFBP4 contains a thyroglobulin type-I domain and binds IGF-II more than IGF-I. IGFBP4 inhibits IGF-induced bone cell proliferation. (from OMIM 146733, SWISS-PROT P22692, and NCI) ( NCI )] (UMLS (NCI) C0123258) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 371. IL-2/MOAB IDEC-C2B8
- (UMLS (NCI) C0678099) =Therapeutic or Preventive Procedure
|
- 322. IGF Binding Protein 5
- [IGFBP5 contains a thyroglobulin type-I domain and belongs to the IGFBP family. IGFBPs display strong sequence homologies. IGFBPs contain three distinct domains. N-terminal domain 1 and C-terminal domain 3 contain invariant cysteine residues and are thought to be the IGF binding domains. Domain 2 generally lacks sequence identity among the IGFBPs. Domain 3 is homologous to the thyroglobulin type I repeat. IGF-I and IGF-II circulate in plasma tightly bound to IGFBPs. IGFs, IGFRs, and IGFBPs regulate cell proliferation and apoptosis; the primary effect of IGFBPs appears to be modulation of IGF activity and control of IGF-mediated cell growth and metabolism. Secreted IGF-binding proteins prolong the half-life of IGFs (somatomedins) and either inhibit or stimulate the growth promoting effects of IGFs; they alter the interaction of IGFs with cell surface receptors. (from OMIM 146734, SWISS-PROT P22692, and NCI) ( NCI )] (UMLS (NCI) C0123259) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 372. IL-2/MOAB Lym-1
- (UMLS (NCI) C0280732) =Therapeutic or Preventive Procedure ;
|
- 323. IGF I
- [Elevated serum levels of insulin-like growth factor-1 (IGF-1) may identify premenopausal women who are likely to develop breast cancer before age 50. (from Int J Cancer 2000;88:828-832 via Medscape) ( NCI )] (UMLS (CSP) C0021665) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 373. IL-2/MOAB OKT3
- (UMLS (NCI) C0338198) =Therapeutic or Preventive Procedure ;
|
- 324. IGF II
- [Insulin-like growth factors I and II, also known as somatomedin C and somatomedin A, respectively, are single chain polypeptides which share an amino acid sequence homology of about 47% with insulin and about 31% with relaxin and with them comprise the insulin family of polypeptide growth factors. Their functions include mediation of growth hormone action, stimulation of growth of cultured cells, stimulation of the action of insulin, and involvement in development and growth. They appear to be autocrine regulators of cell proliferation. ( NCI )] (UMLS (CSP) C0021666) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 374. IL-2/MOAB OKT3/PTX
- (UMLS (NCI) C0338201) =Therapeutic or Preventive Procedure
|
- 325. IGF Receptor
- [The protein on surface of target cells specific for binding IGF. There are two types of IGF receptor, one of which closely resembles the insulin receptor. ( NCI )] (UMLS (NCI) C0140079) =Amino Acid, Peptide, or Protein; Receptor
| - 375. IL-2/MOAB OKT3/TNF
- (UMLS (NCI) C0338199) =Therapeutic or Preventive Procedure ;
|
- 326. IGF-II mRNA-Binding Protein 3
- [Encoded by human KOC1 Gene, IGF-II mRNA-Binding Protein 3 contains a KH domain and binds to the 5-prime UTR of the IGF-II leader 3-prime mRNA. It may repress translation of IGF-II during late development. (from LocusLink and NCI) ( NCI )] (UMLS (NCI) C0539906) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 376. IL-2/MOAB R24
- (UMLS (NCI) C0280888) =Therapeutic or Preventive Procedure
|
- 327. IGF1
- [This gene is involved in cellular communication, growth and proliferation. It also plays a role in the regulation of muscular and skeletal development. ( NCI )] (UMLS (NCI) C1334089) IGF1 Gene;
Insulin-Like Growth Factor 1 (Somatomedin C) Gene =Gene or Genome | - 377. IL-2/NMA
- (UMLS (NCI) C0281762) =Therapeutic or Preventive Procedure
|
- 328. IGF1R
- [Human insulin-like growth factor-1 receptor protein (1367 aa, 155 kDa precursor) is encoded by the human insulin-like growth factor-1 (IGFR1) gene. This membrane-bound protein, a disulfide-linked alpha2/beta2 tetramer, binds both insulin growth factors I and II. Ligand binding activates protein kinase activity, controls cell cycle progression and enhances cell survival. ( NCI )] (UMLS (NCI) C0140080) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
| - 378. IL-2/PEG-IL-2
- (UMLS (NCI) C0280911) =Therapeutic or Preventive Procedure
|
- 329. IGF1R
- [This gene is involved in the regulation of apoptosis and cell proliferation and plays a role in cellular transformation and malignancy. ( NCI )] (UMLS (NCI) C1334088) IGF1R Gene;
Insulin-Like Growth Factor 1 Receptor Gene =Gene or Genome | - 379. IL-2/Poly ICLC
- (UMLS (NCI) C0278658) =Therapeutic or Preventive Procedure
|
- 330. IGF2
- [This gene plays a role in cell growth and proliferation. It is also involved in the regulation of prenatal skeletal and muscular development. ( NCI )] (UMLS (NCI) C1334091) IGF2 Gene;
Insulin-Like Growth Factor 2 (Somatomedin A) Gene =Gene or Genome | - 380. IL-2/ras pep vac
- (UMLS (NCI) C0796495) Interleukin-2/Ras Peptide Cancer Vaccine;
=Therapeutic or Preventive Procedure ;
|
- 331. IGF2R
- [This gene is involved in intracellular trafficking and receptor signaling. ( NCI )] (UMLS (NCI) C1334090) IGF2R Gene;
Insulin-Like Growth Factor 2 Receptor Gene =Gene or Genome | - 381. IL-2/TIL
- (UMLS (NCI) C0280618) =Therapeutic or Preventive Procedure
|
- 332. IGFBP1
- [This gene plays a role in insulin-like growth factor modulation and degradation. ( NCI )] (UMLS (NCI) C1334092) IGFBP1 Gene;
Insulin-Like Growth Factor Binding Protein 1 Gene =Gene or Genome | - 382. IL-2/TNF
- (UMLS (NCI) C0280613) =Therapeutic or Preventive Procedure
|
- 333. IGFBP2
- [This gene plays a role in insulin-like growth factor modulation and intercellular communication. ( NCI )] (UMLS (NCI) C1334093) IGFBP2 Gene;
Insulin-Like Growth Factor Binding Protein 2, 36kDa Gene =Gene or Genome | - 383. IL-2/TNFR:Fc
- (UMLS (NCI) C0281501) =Therapeutic or Preventive Procedure
|
- 334. IGFBP3
- [This gene plays an inhibitory role in the regulation of extravascular tissue growth. ( NCI )] (UMLS (NCI) C1334094) IGFBP3 Gene;
Insulin-Like Growth Factor Binding Protein 3 Gene =Gene or Genome | - 384. IL-2/TSPA
- (UMLS (NCI) C0279274) =Therapeutic or Preventive Procedure ;
|
- 335. IGFBP4
- [This gene plays a role in insulin-like growth factor modulation and cellular growth inhibition. ( NCI )] (UMLS (NCI) C1334095) IGFBP4 Gene;
Insulin-Like Growth Factor Binding Protein 4 Gene =Gene or Genome | - 385. IL-2/VBL
- (UMLS (NCI) C0281738) =Therapeutic or Preventive Procedure
|
- 336. IGFBP5
- [This gene plays a role in the intracellular transport of insulin-like growth factor moieties. ( NCI )] (UMLS (NCI) C1334096) IGFBP5 Gene;
Insulin-Like Growth Factor Binding Protein 5 Gene =Gene or Genome | - 386. IL-2/ZDV
- (UMLS (NCI) C0278673) =Therapeutic or Preventive Procedure
|
- 337. IGFBP6
- [This gene plays an inhibitory role in the regulation of cellular growth. ( NCI )] (UMLS (NCI) C1367148) IGFBP6 Gene;
Insulin-Like Growth Factor Binding Protein 6 Gene =Gene or Genome ◊ [IGFBP6 contains a thyroglobulin type-I domain, belongs to the IGFBP family, and may function as an autocrine growth inhibitor. IGFBPs display strong sequence homologies. IGFBPs contain three distinct domains. N-terminal domain 1 and C-terminal domain 3 contain invariant cysteine residues and are the IGF binding domains. Domain 2 generally lacks sequence identity among the IGFBPs. Domain 3 is homologous to the thyroglobulin type I repeat. IGF-I and IGF-II circulate in plasma tightly bound to IGFBPs. IGFs, IGFRs, and IGFBPs regulate cell proliferation and apoptosis and the primary effect of IGFBPs appears to be modulation of IGF activity and control of IGF-mediated cell growth and metabolism. Secreted IGF-binding proteins prolong the half-life of IGFs (somatomedins) and either inhibit or stimulate the growth promoting effects of IGFs by altering the interaction of IGFs with cell surface receptors. (from OMIM 146735, SWISS-PROT P24592 and NCI) ( NCI )] (UMLS (NCI) C1442822) Amino Acid, Peptide, or Protein; Biologically Active Substance | - 387. IL-2/ZnO
- (UMLS (NCI) C0338215) =Therapeutic or Preventive Procedure
|
- 338. IGFBP9
- [A product of the NOV gene. It is a member of the CCN family of proteins, expressed after induction by growth factors. CCN proteins share several motifs: an IGFBP motif, an oligomeric complex-forming domain, a binding domain for soluble and matrix molecules, and a dimerization CT domain. All CCN members are thought to control cell proliferation. (from OMIM 164958 and NCI) ( NCI )] (UMLS (NCI) C1334190) Insulin-Like Growth Factor-Binding Protein-9;
NOV =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 388. IL-3 Receptor
- [Heterodimeric human Interleukin 3 Receptor is composed of 378-aa 43-kDa (precursor) Interleukin 3 Receptor Alpha and GM-CSF/IL-3/IL-5 Receptor Common Beta-Chain. IL3RA is a type I membrane protein with a box 1 motif for JAK interaction/activation and a WSXWS motif for protein folding, intracellular transport, and cell-surface receptor binding. Receptor binding to IL3 depends on the signal transducing beta subunit, common to the high affinity IL3-, IL5- and GM-CSF receptors. (NCI) ( NCI )] (UMLS (NCI) C0080096) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor ;
|
- 339. IgG
- [major immunoglobulin in normal human serum, distributed evenly between the intravascular and extravascular pools; it is the major antibody of secondary immune responses and the exclusive antitoxin class. ( CSP )] (UMLS (NCI) C0020852) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor =[IM500] IMMUNOGLOBULINS;
=RHO (D) IMMUNE GLOBULIN,HUMAN;
Anti-CD3 Monoclonal Antibody OKT3;
TNFR-Fc fusion protein;
Anti-Tac | - 389. IL-3/IL-6
- (UMLS (NCI) C0281445) =Therapeutic or Preventive Procedure
|
- 340. IgG2a murine monoclonal antibody Lym-1
- [A murine IgG2a monoclonal antibody directed against the HLA-Dr10 protein, a cell surface marker present on over eighty percent of lymphoma cells. When conjugated with a radioactive isotope, Lym-1 monoclonal antibody selectively transports the cytotoxic radioisotope to HLA-Dr10-expressing tumor cells, thereby sparing healthy B-cells and normal tissues. This agent also mediates antibody-dependent cytotoxicity thereby promoting Raji B-lymphoid cell lysis by human neutrophils. (NCI04) ( NCI )] (UMLS (NCI) C0280726) =Amino Acid, Peptide, or Protein; Immunologic Factor
| - 390. IL-3/L-PAM
- (UMLS (NCI) C0281245) =Therapeutic or Preventive Procedure ;
|
- 341. IGH
- [This region represents the germline organization of the immunoglobulin heavy chain locus. The locus includes V (variable), J (joining), diversity (D), and C (constant) segments. During B cell development, a recombination event at the DNA level joins a D segment with a J segment; a V segment is then joined to the D-J gene. The C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several D and J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase, and by somatic hypermutation, which occurs during B cell maturation in the spleen and lymph nodes. (from LocusLink) ( NCI )] (UMLS (NCI) C0017351) =Gene or Genome
| - 391. IL-3/TSPA
- (UMLS (NCI) C0281196) =Therapeutic or Preventive Procedure
|
- 342. Igiugig Village
- (UMLS (HL7) C1550875) =Population Group =NativeEntityAlaska;
| - 392. IL-3/ZDV
- (UMLS (NCI) C0281252) =Therapeutic or Preventive Procedure ;
|
- 343. IGK
- [This region represents the germline organization of the kappa light chain locus. The locus includes V (variable), J (joining), and C (constant) segments. During B cell development, a recombination event at the DNA level joins a single V segment with a J segment; the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase, and by somatic hypermutation, which occurs during B cell maturation in the spleen and lymph nodes. (from LocusLink) ( NCI )] (UMLS (NCI) C1366332) Immunoglobulin Kappa Gene;
Immunoglobulin Kappa Locus;
Kappa Light Chain Gene =Gene or Genome | - 393. IL-4 Fusion Toxin
- [A substance that is being studied as an anticancer drug. It belongs to the family of drugs called recombinant chimeric proteins. Also called NBI-3001. ( NCI )] (UMLS (NCI) C1313726) IL-4 PE38KDEL Immunotoxin;
Interleukin-4 Fusion Toxin;
interleukin-4 PE38KDEL cytotoxin;
interleukin-4 pe38kdel immunotoxin;
Interleukin-4 Pseudomonas Exotoxin;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor |
- 344. IGL
- [This region represents the germline organization of the lambda light chain locus. The locus includes V (variable), J (joining), and C (constant) segments. During B cell development, a recombination event at the DNA level joins a single V segment with a J segment; the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase, and by somatic hypermutation, which occurs during B cell maturation in the spleen and lymph nodes. (from LocusLink) ( NCI )] (UMLS (NCI) C1334165) Immunoglobulin Lambda Gene;
Immunoglobulin Lambda Locus;
Lambda Light Chain Gene =Gene or Genome ;
| - 394. IL1
- [macrophage produced interleukin that induces the production of interleukin 2 by T cells that have been stimulated by antigen or mitogen; at least two types, alpha and beta, exist; interleukin 1 or a similar protein is also produced by epithelial cells and stimulates fibroblast proliferation and release of proteolytic enzymes and prostaglandins in inflammatory processes. ( CSP )] (UMLS (NCI) C0021755) =Amino Acid, Peptide, or Protein; Immunologic Factor =Cytokine;
hematopoietic growth factor |
- 345. IgM
- [pentameric immunoglobulin largely confined to the intravascular pool and the predominant early antibody frequently seen in the immune response to antigenically complex infectious organisms. ( CSP )] (UMLS (NCI) C0020861) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
=[IM500] IMMUNOGLOBULINS;
| - 395. IL1 convertase enzyme
- [ ] (UMLS (CSP) C0543491) =Amino Acid, Peptide, or Protein; Enzyme
|
- 346. Ignore
- [Ignore this role, it is not relevant to the update. ( HL7V3.0 )] (UMLS (HL7) C1554079) =Idea or Concept =HL7UpdateMode;
| - 396. IL10
- [This gene plays an anti-inflammatory role in immune processes and is involved in a variety of diseases. ( NCI )] (UMLS (NCI) C1334098) IL10 Gene;
Interleukin 10 Gene =Gene or Genome |
- 347. iguana
- [Large herbivorous tropical American lizards. ( MSH )] (UMLS (CSP) C0020864) =Reptile
| - 397. IL10RB
- [This protein belongs to the cytokine receptor family. It is an accessory chain essential for the active interleukin 10 receptor complex. Coexpression of this and IL10RA proteins has been shown to be required for IL10-induced signal transduction. ( NCI )] (UMLS (NCI) C0217502) =Amino Acid, Peptide, or Protein; Receptor ;
|
- 348. IIIrd Cranial Nerve Neoplasm, Malignant
- (UMLS (NCI) C0686417) =Neoplastic Process
| - 398. IL10RB
- [This gene plays a role in cytokine regulation and signal transduction. ( NCI )] (UMLS (NCI) C1334097) IL10RB Gene;
Interleukin 10 Receptor, Beta Gene =Gene or Genome |
- 349. IIIrd Nerve Paralysis
- [Diseases of the oculomotor nerve or nucleus that result in weakness or paralysis of the superior rectus, inferior rectus, medial rectus, inferior oblique, or levator palpebrae muscles, or impaired parasympathetic innervation to the pupil. With a complete oculomotor palsy, the eyelid will be paralyzed, the eye will be in an abducted and inferior position, and the pupil will be markedly dilated. Commonly associated conditions include neoplasms, CRANIOCEREBRAL TRAUMA, ischemia (especially in association with DIABETES MELLITUS), and aneurysmal compression. (From Adams et al., Principles of Neurology, 6th ed, p270) ( MSH )] (UMLS (NCI) C0028866) =Disease or Syndrome =eye movement disorder;
=Adie Syndrome | - 399. IL11
- [This gene plays a role in the regulation of cell proliferation and differentiation. ( NCI )] (UMLS (NCI) C1334100) IL11 Gene;
Interleukin 11 Gene =Gene or Genome |
- 350. IL
- [A state in the central midwest United States. Its capital is Springfield. ( NCI )] (UMLS (NCI) C0020898) =Geographic Area ;
◊ [Middle Eastern country bordering on the Mediterranean, republic established 1948, capital city is Jerusalem. ( CSP )] (UMLS (NCI) C0022271) Geographic Area ; Middle East; | - 400. IL11RA
- [This gene is involved in interleukin 11 receptor mediation and signal transduction. ( NCI )] (UMLS (NCI) C1334099) IL11RA Gene;
Interleukin 11 Receptor, Alpha Gene =Gene or Genome ◊ [This protein is the alpha subunit of the high-affinity receptor for interleukin-11. This particular receptor is very similar to ciliary neurotrophic factor, since both contain an extracellular region with a 2-domain structure composed of an immunoglobulin-like domain and a cytokine receptor-like domain. (LocusLink) ( NCI )] (UMLS (NCI) C1334200) Interleukin 11 Receptor Alpha; Amino Acid, Peptide, or Protein; Receptor ; |
home
